Empagliflozin inhibits excessive autophagy through the AMPK/GSK3ß signalling pathway in diabetic cardiomyopathy.
Cardiovasc Res
; 119(5): 1175-1189, 2023 05 22.
Article
in En
| MEDLINE
| ID: mdl-36627733
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
Diabetic Cardiomyopathies
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Cardiovasc Res
Year:
2023
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido